Phytosphingosine
|
Basic information |
| Metabolite name | Phytosphingosine |
 | HMDB0004610 |
 |
C12144 |
 |
122121 |
| Synonyms | D-ribo-Phytosphingosine |
| No. of studies | 20 |
|
Basic information |
| Metabolite name | Phytosphingosine |
| HMDB0004610 |
|
C12144 |
|
122121 |
| Synonyms | D-ribo-Phytosphingosine |
| No. of studies | 20 |
|
Relationship between Phytosphingosine and depression (count: 20) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M007 | Type1 | CRS group vs. control group | Urine | Wistar rat | Up |
| Study M048 | Type1 | CVS group vs. control group | Serum | Wistar rat | Down |
| Study M048 | Type2 | CVS + fluoxetine group vs. CVS group | Serum | Wistar rat | Up |
| Study M048 | Type2 | CVS + CSGS group vs. CVS group | Serum | Wistar rat | Up |
| Study M1039 | Type1 | CUMS group vs. control group | Liver | Sprague-Dawley rat | Up |
| Study M1039 | Type2 | CUMS + high dose of Angelicae Sinensis Radix group vs. CUMS group | Liver | Sprague-Dawley rat | Down |
| Study M1039 | Type2 | CUMS + low dose of Angelicae Sinensis Radix group vs. CUMS group | Liver | Sprague-Dawley rat | Down |
| Study M1054 | Type1 | CUMS group vs. control group | Plasma | ICR mouse | Down |
| Study M1054 | Type2 | CUMS + ChaihuYujinxiang granules group vs. CUMS group | Plasma | ICR mouse | Up |
| Study M204 | Type1 | LPS group vs. control group | Hypothalamus | CD-1 mouse | Up |
| Study M207 | Type1 | depressed group vs. control group | Hippocampus | Kunming mouse | Up |
| Study M512 | Type1 | CUMS group vs. control group | Urine | Goto-Kakizaki rat | Up |
| Study M541 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Up |
| Study M569 | Type2 | LPS + HPF group vs. LPS group | Serum | ICR mouse | Down |
| Study M571 | Type1 | LPS group vs. control group | Hypothalamus | CD-1 mouse | Up |
| Study M633 | Type1 | corticosterone group vs. control group | Urine | C57BL/6 mouse | Up |
| Study M681 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Up |
| Study M681 | Type2 | CUMS + Chaihu Shu Gan San group vs. CUMS group | Serum | Sprague-Dawley rat | Down |
| Study M789 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Up |
| Study M789 | Type2 | CUMS + liquiritin group vs. CUMS group | Plasma | Sprague-Dawley rat | Down |
| Study M789 | Type2 | CUMS + fluoxetine group vs. CUMS group | Plasma | Sprague-Dawley rat | Down |
| Study M846 | Type2 | postpartum depression model + 919 syrup group vs. postpartum depression model group | Faece | BALB/c mouse | Down |
| Study M847 | Type1 | CUMS group vs. control group | Liver | Sprague-Dawley rat | Down |
| Study M853 | Type1 | depression group vs. control group | Plasma | Human | Down |
| Study M869 | Type1 | CUMS group vs. control group | Peripheral blood mononuclear cell | Sprague-Dawley rat | Down |
| Study M870 | Type1 | CRS group vs. control group | Brain | C57BL/6 mouse | Down |
| Study M870 | Type2 | CRS + sertraline group vs. CRS group | Brain | C57BL/6 mouse | Up |
| Study M870 | Type2 | CRS + middle dose of Jia Wei Xiao Yao San group vs. CRS group | Brain | C57BL/6 mouse | Up |
| Study M936 | Type1 | SD group vs. control group | Faece | Sprague-Dawley rat | Down |
| Study M953 | Type1 | CRS group vs. control group | Faece | Sprague-Dawley rat | Up |
| Study M953 | Type2 | CRS + Shugan Granule group vs. CRS group | Faece | Sprague-Dawley rat | Down |